A detailed history of Northstar Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Northstar Asset Management Inc holds 151,131 shares of NVO stock, worth $21.6 Million. This represents 3.55% of its overall portfolio holdings.

Number of Shares
151,131
Previous 153,344 1.44%
Holding current value
$21.6 Million
Previous $15.9 Billion 99.88%
% of portfolio
3.55%
Previous 4.58%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $225,969 - $300,790
-2,213 Reduced 1.44%
151,131 $19.4 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $56,091 - $67,382
-639 Reduced 0.41%
153,344 $15.9 Billion
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $5.11 Million - $11.2 Million
56,238 Added 57.54%
153,983 $14 Billion
Q2 2023

Aug 03, 2023

SELL
$155.98 - $172.65 $2.94 Million - $3.25 Million
-18,843 Reduced 16.16%
97,745 $15.8 Billion
Q1 2023

Apr 27, 2023

SELL
$132.34 - $159.14 $909,043 - $1.09 Million
-6,869 Reduced 5.56%
116,588 $18.6 Billion
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $12.7 Million - $16.7 Million
123,457 New
123,457 $16.7 Billion
Q3 2022

May 15, 2023

BUY
$95.28 - $116.93 $1.99 Million - $2.44 Million
20,903 Added 20.49%
122,895 $12.2 Billion
Q2 2022

May 15, 2023

SELL
$103.24 - $121.81 $502,778 - $593,214
-4,870 Reduced 4.56%
101,992 $11.4 Billion
Q1 2022

May 15, 2023

SELL
$93.1 - $112.54 $1.78 Million - $2.16 Million
-19,170 Reduced 15.21%
106,862 $11.9 Billion
Q4 2021

May 15, 2023

SELL
$95.88 - $117.08 $425,707 - $519,835
-4,440 Reduced 3.4%
126,032 $14.1 Billion
Q3 2021

May 15, 2023

BUY
$84.42 - $106.62 $39,930 - $50,431
473 Added 0.36%
130,472 $12.5 Billion
Q2 2021

May 15, 2023

BUY
$67.66 - $84.76 $515,636 - $645,955
7,621 Added 6.23%
129,999 $10.9 Billion
Q1 2021

May 15, 2023

BUY
$67.06 - $75.82 $388,277 - $438,997
5,790 Added 4.97%
122,378 $8.25 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northstar Asset Management Inc Portfolio

Follow Northstar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Asset Management Inc with notifications on news.